litlas
ログインアカウント作成

Robert Dreicer

1984–2025 年に発表

104
論文数
33,183
被引用数
75
h 指数
100
i10 指数

被引用数

Robert Dreicer の年別被引用数1948 年: 被引用 1 件1985 年: 被引用 2 件1986 年: 被引用 2 件1987 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 2 件1991 年: 被引用 1 件1993 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 9 件1997 年: 被引用 17 件1998 年: 被引用 25 件1999 年: 被引用 13 件2000 年: 被引用 17 件2001 年: 被引用 15 件2002 年: 被引用 29 件2003 年: 被引用 27 件2004 年: 被引用 19 件2005 年: 被引用 32 件2006 年: 被引用 27 件2007 年: 被引用 34 件2008 年: 被引用 47 件2009 年: 被引用 108 件2010 年: 被引用 139 件2011 年: 被引用 212 件2012 年: 被引用 205 件2013 年: 被引用 229 件2014 年: 被引用 233 件2015 年: 被引用 213 件2016 年: 被引用 277 件2017 年: 被引用 423 件2018 年: 被引用 455 件2019 年: 被引用 1,242 件2020 年: 被引用 1,265 件2021 年: 被引用 1,347 件2022 年: 被引用 930 件2023 年: 被引用 761 件2024 年: 被引用 1,237 件2025 年: 被引用 520 件2026 年: 被引用 17 件1949〜1984 年は被引用が無いため表示していません1992 年は被引用が無いため表示していません1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,001 件、この内訳の 26.7%中国: 引用元論文 1,406 件、この内訳の 9.4%イギリス: 引用元論文 926 件、この内訳の 6.2%ドイツ: 引用元論文 843 件、この内訳の 5.6%イタリア: 引用元論文 815 件、この内訳の 5.4%フランス: 引用元論文 726 件、この内訳の 4.9%カナダ: 引用元論文 633 件、この内訳の 4.2%スペイン: 引用元論文 501 件、この内訳の 3.4%日本: 引用元論文 461 件、この内訳の 3.1%オランダ: 引用元論文 430 件、この内訳の 2.9%オーストラリア: 引用元論文 422 件、この内訳の 2.8%スイス: 引用元論文 391 件、この内訳の 2.6%
0%26.7%その他 22.8%

機関

分野

  • Medicine73.5%
  • Biochemistry, Genetics and Molecular Biology11.5%
  • Immunology and Microbiology11.2%
  • Engineering1.2%
  • Materials Science0.9%
  • Computer Science0.3%
  • その他1.4%

トピック

  • Cancer Immunotherapy and Biomarkers10.1%
  • Prostate Cancer Treatment and Research10.1%
  • Immunotherapy and Immune Responses5.8%
  • Bladder and Urothelial Cancer Treatments5.6%
  • Prostate Cancer Diagnosis and Treatment5.6%
  • Radiopharmaceutical Chemistry and Applications3.5%
  • その他59.3%

共著者

全論文

検索で開く
  1. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

    著者: Philip W. Kantoff, Celestia S. Higano, Neal D. Shore, E. Roy Berger, Eric J. Small, David F. Penson, Charles H. Redfern, Anna C. Ferrari, Robert Dreicer, Robert B. Sims, Yi Xu, Mark W. Frohlich, Paul F. Schellhammer - New England Journal of Medicine 2010 被引用: 5,492

  2. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

    著者: Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer - The Lancet 2016 被引用: 3,714

  3. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    著者: Howard I. Scher, Michael J. Morris, Walter M. Stadler, Celestia S. Higano, Ethan Basch, Karim Fizazi, Emmanuel S. Antonarakis, Tomasz M. Beer, Michael A. Carducci, Kim N., Paul G. Corn, Johann S. de Bono, Robert Dreicer, Daniel J. George, Elisabeth I. Heath, Maha Hussain, Wm. Kevin Kelly, Glenn Liu, Christopher J. Logothetis, David M. Nanus, Mark N. Stein, Dana E. Rathkopf, Susan F. Slovin, Charles J. Ryan, Oliver Sartor, Eric J. Small, Matthew Raymond Smith, Cora N. Sternberg, Mary-Ellen Taplin, George Wilding, Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 被引用: 1,603

  4. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

    著者: Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard, Mario A. Eisenberger, Yu-Ning Wong, Noah M. Hahn, Manish Kohli, Matthew M. Cooney, Robert Dreicer, Nicholas J. Vogelzang, Joel Picus, Daniel H. Shevrin, Maha Hussain, Jorge A. García, Robert S. DiPaola - New England Journal of Medicine 2015 被引用: 2,835

  5. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

    著者: Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg, Thomas Powles, Daniel P. Petrylak, Joaquim Bellmunt, Yohann Loriot, Andrea Necchi, Jean Hoffman‐Censits, José Luis Perez‐Gracia, Nancy A. Dawson, Michiel S. van der Heijden, Robert Dreicer, Sandy Srinivas, Margitta Retz, Richard W. Joseph, Alexandra Drakaki, Ulka N. Vaishampayan, Srikala S. Sridhar, David I. Quinn, Ignacio Durán, David R. Shaffer, Bernhard J. Eigl, Petros Grivas, Evan Y. Yu, Shi Li, Edward E. Kadel, Zachary Boyd, Richard Bourgon, Priti S. Hegde, Sanjeev Mariathasan, AnnChristine Thåström, Oyewale O. Abidoye, Gregg Fine, Dean F. Bajorin - The Lancet 2016 被引用: 2,211

  6. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

    著者: Christos E. Kyriakopoulos, Yu‐Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard, Noah M. Hahn, Daniel H. Shevrin, Robert Dreicer, Maha Hussain, Mario A. Eisenberger, Manish Kohli, Elizabeth R. Plimack, Nicholas J. Vogelzang, Joel Picus, Matthew M. Cooney, Jorge A. García, Robert S. DiPaola, Christopher J. Sweeney - Journal of Clinical Oncology 2018 被引用: 1,106

  7. Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC).

    著者: Xīn Gào, Howard A. Burris, Jacqueline Vuky, Robert Dreicer, Oliver Sartor, Cora N. Sternberg, Ivor Percent, Maha Hussain, Arash Rezazadeh Kalebasty, John Shen, Elisabeth I. Heath, Guillermo Abesada‐Terk, Sunil Gandhi, Meredith McKean, Haolan Lu, Elmer Berghorn, Richard Gedrich, S. Debbie Chirnomas, Nicholas J. Vogelzang, Daniel P. Petrylak - Journal of Clinical Oncology 2022 被引用: 186

  8. Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023)

    著者: William T. Lowrance, Robert Dreicer, David F. Jarrard, Kristen R. Scarpato, Sennett K. Kim, Erin Kirkby, David Buckley, Jessica Griffin, Michael S. Cookson - The Journal of Urology 2023 被引用: 290

  9. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

    著者: Sam S. Chang, Bernard H. Bochner, Roger Chou, Robert Dreicer, Ashish M. Kamat, Seth P. Lerner, Yair Lotan, Joshua J. Meeks, Jeff M. Michalski, Todd M. Morgan, Diane Zipursky Quale, Jonathan E. Rosenberg, Anthony L. Zietman, Jeffrey M. Holzbeierlein - The Journal of Urology 2017 被引用: 940

  10. Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy

    著者: Matthew D. Galsky, Noah M. Hahn, Jonathan Rosenberg, Guru Sonpavde, Thomas E. Hutson, William Oh, Robert Dreicer, Nicholas J. Vogelzang, Cora N. Sternberg, Dean F. Bajorin, Joaquim Bellmunt - Journal of Clinical Oncology 2011 被引用: 688

  11. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

    著者: Howard I. Scher, Susan Halabi, Ian F. Tannock, Michael J. Morris, Cora N. Sternberg, Michael A. Carducci, Mario A. Eisenberger, Celestia S. Higano, Glenn J. Bubley, Robert Dreicer, Daniel Petrylak, Philip W. Kantoff, Ethan Basch, William Kevin Kelly, William D. Figg, Eric J. Small, Tomasz M. Beer, George Wilding, Alison Martin, Maha Hussain - Journal of Clinical Oncology 2008 被引用: 2,241

  12. Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer

    著者: Karen A. Autio, Robert Dreicer, Justine Anderson, Jorge A. García, Ajjai Alva, Lowell L. Hart, Matthew I. Milowsky, Edwin M. Posadas, Charles J. Ryan, Ryon P. Graf, Ryan Dittamore, Nicole A. Schreiber, Jason M. Summa, Hagop Youssoufian, Michael J. Morris, Howard I. Scher - JAMA Oncology 2018 被引用: 253

  13. CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors

    著者: Emmanuel S. Antonarakis, Pedro Isaacsson Velho, Wei Fu, Hao Wang, Neeraj Agarwal, Víctor Sacristán Santos, Benjamin L. Maughan, Роберто Пили, Nabil Adra, Cora N. Sternberg, Panagiotis J. Vlachostergios, Scott T. Tagawa, Alan H. Bryce, Andrea McNatty, Zachery R. Reichert, Robert Dreicer, Oliver Sartor, Tamara L. Lotan, Maha Hussain - JCO Precision Oncology 2020 被引用: 206

  14. Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study

    著者: Sumanta K. Pal, Bradley McGregor, Cristina Suárez, Che-Kai Tsao, William Kelly, Ulka Vaishampayan, Lance Pagliaro, Benjamin L. Maughan, Yohann Loriot, Daniel Castellano, Sandy Srinivas, Rana R. McKay, Robert Dreicer, Thomas Hutson, Sarita Dubey, Scott Werneke, Ashok Panneerselvam, Dominic Curran, Christian Scheffold, Toni K. Choueiri, Neeraj Agarwal - Journal of Clinical Oncology 2021 被引用: 140

  15. Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)

    著者: Neeraj Agarwal, Bradley A. McGregor, Benjamin L. Maughan, Tanya B. Dorff, William Kevin Kelly, Bruno Fang, Rana R. McKay, Parminder Singh, Lance C. Pagliaro, Robert Dreicer, Sandy Srinivas, Yohann Loriot, Ulka N. Vaishampayan, Sanjay Goel, Dominic Curran, Ashok Panneerselvam, Martin Schwickart, Toni K. Choueiri, Sumanta K. Pal - The Lancet Oncology 2022 被引用: 66

  16. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy

    著者: Matthew D. Galsky, Noah M. Hahn, Jonathan E. Rosenberg, Guru Sonpavde, Thomas E. Hutson, William Oh, Robert Dreicer, Nicholas J. Vogelzang, Cora N. Sternberg, Dean F. Bajorin, Joaquim Bellmunt - The Lancet Oncology 2011 被引用: 345

  17. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I

    著者: William T. Lowrance, Rodney H. Breau, Roger Chou, Brian F. Chapin, Tony Crispino, Robert Dreicer, David F. Jarrard, Adam S. Kibel, Todd M. Morgan, Alicia K. Morgans, William Oh, Matthew J. Resnick, Anthony L. Zietman, Michael S. Cookson - The Journal of Urology 2020 被引用: 266

  18. Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients

    著者: James H. Finke, Brian I. Rini, Joanna Ireland, Patricia Rayman, Amy L. Richmond, Ali Golshayan, Laura S. Wood, Paul Elson, J. Luz Tovar García, Robert Dreicer, Ronald M. Bukowski - Clinical Cancer Research 2008 被引用: 485

  19. Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies

    著者: Gwénaëlle Gravis, Jean‐Marie Boher, Yu‐Hui Chen, Glenn Liu, Karim Fizazi, Michael A. Carducci, Stéphane Oudard, Florence Joly, David Jarrard, M. Soulié, Mario Eisenberger, Muriel Habibian, Robert Dreicer, Jorge A. García, Maha H.M. Hussain, Manish Kohli, Nicholas J. Vogelzang, Joel Picus, Robert S. DiPaola, Christopher J. Sweeney - European Urology 2018 被引用: 247

  20. Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

    著者: Jennifer S. Ko, Arnold H. Zea, Brian I. Rini, Joanna Ireland, Paul Elson, Peter A. Cohen, Ali Golshayan, Patricia Rayman, Laura S. Wood, Jorge A. García, Robert Dreicer, Ronald M. Bukowski, James H. Finke - Clinical Cancer Research 2009 被引用: 852

  21. Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma

    著者: Matthew D. Galsky, G. J. Chen, William Oh, Joaquim Bellmunt, Bruce J. Roth, Roberto Petrioli, Luigi Dogliotti, Robert Dreicer, Guru Sonpavde - Annals of Oncology 2011 被引用: 290

  22. Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials

    著者: Glenn Heller, Robert McCormack, Thian Kheoh, Arturo Molina, Matthew R. Smith, Robert Dreicer, Fred Saad, Ronald de Wit, Dana T. Aftab, Mohammad Hirmand, Ana Limon, Karim Fizazi, Martin Fleisher, Johann S. de Bono, Howard I. Scher - Journal of Clinical Oncology 2017 被引用: 230

  23. Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)

    著者: Maha Hussain, Masha Kocherginsky, Neeraj Agarwal, Nabil Adra, Jingsong Zhang, Channing J. Paller, Joel Picus, Zachery R. Reichert, Russell Z. Szmulewitz, Scott T. Tagawa, Timothy M. Kuzel, Latifa A. Bazzi, Stephanie Daignault‐Newton, Young E. Whang, Robert Dreicer, Ryan D. Stephenson, Matthew B. Rettig, Daniel H. Shevrin, Travis Gerke, Arul M. Chinnaiyan, Emmanuel S. Antonarakis - Clinical Cancer Research 2024 被引用: 44

  24. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel

    著者: Lauren C. Harshman, Yu‐Hui Chen, Glenn Liu, Michael A. Carducci, David F. Jarrard, Robert Dreicer, Noah M. Hahn, Jorge A. García, Maha Hussain, Daniel H. Shevrin, Mario A. Eisenberger, Manish Kohli, Elizabeth R. Plimack, Matthew M. Cooney, Nicholas J. Vogelzang, Joel Picus, Robert S. DiPaola, Christopher J. Sweeney, on behalf of the ECOG-ACRIN 3805 Investigators - Journal of Clinical Oncology 2017 被引用: 123